You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Claims for Patent: 4,129,647

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 4,129,647

Title:	Treatment of acne
Abstract:	A method for the immuno-therapeutic control and treatment of acne by administering an effective amount for treatment of an immunological preparation comprising an immunogen and at least one anti-mitotic adjuvant agent together with a pharmaceutically acceptable carrier.
Inventor(s):	Klein; Edmund (Williamsville, NY)
Assignee:
Application Number:	05/843,053
Patent Claims:	1. A method for the therapeutic control and treatment of acne which comprises administering to a patient an immunogen selected from the group consisting of dinitrochlorobenzene and Bacillus Calmette-Guerin Vaccine which induces or potentiates an immune response on local administration in an amount sufficient to induce a delayed hypersensitivity reaction and thereafter applying to the skin of said patient an immunological preparation in an immunologically effective amount for the treatment of acne, said preparation comprising an immunogen selected from the group consisting of dinitrochlorobenzene and Bacillus Calmette-Guerin Vaccine together with a pharmaceutically acceptable carrier. 2. A method according to claim 1 wherein said immunogen is dinitrochlorobenzene. 3. A method according to claim 2 wherein the pharmaceutically acceptable carrier is a gel. 4. A method according to claim 1 wherein said immunogen is administered concurrently with at least one anti-mitotic agent. 5. A method according to claim 4 wherein the immunogen is dinitrochlorobenzene and the anti-mitotic agent is 5-fluorouracil. 6. A method according to claim 4 wherein said anti-mitotic agent is 5-fluorouracil, uracil or mixtures thereof. 7. A method according to claim 1 wherein said immunological preparation further comprises at least one anti-mitotic agent. 8. A method according to claim 7 wherein said anti-mitotic agent is 5-fluorouracil, uracil or mixtures thereof. 9. A method according to claim 1 wherein said immunogen is administered concurrently with at least one anti-mitotic agent to induce said hypersensitivity reaction and said immunological preparation further comprises at least one anti-mitotic agent.

Details for Patent 4,129,647

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Teknika Llc	TICE BCG	bcg live	For Injection	102821	06/21/1989	⤷ Try a Trial	2040-01-28
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.